Jonatan Constan News Today

Since the start of the COVID-19 pandemic, a class of corticosteroids called glucocorticoids (GCs) have become established as one of the main treatment options, especially for severe cases, thanks to their anti-inflammatory and immunosuppressant action.

Brazilian researchers observed an increase in production of endocannabinoid, a natural anti-inflammatory neurotransmitter, in COVID-19 patients given glucocorticoids. The discovery points to possibilities of novel treatments for various inflammatory and neurological diseases.